Clinical Trial Update: Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects [Phase 2]

View source ↗

Summary

A Phase 2 study assessing metabolic toxicities of combining Lopinavir/ritonavir with Saquinavir mesylate or Lamivudine/Zidovudine in HIV-infected subjects; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Epivir (Lamivudine)
• Invirase (saquinavir)
• Kaletra (lopinavir)
• RETROVIR (Zidovudine)

Snippet

Sponsor: Abbott | Conditions: HIV Infections | Phase 2 | Status: COMPLETED